Literature DB >> 25916091

Metastatic lymph node ratio and prognosis of gastric cancer at different pT stages.

Xiaobao Li, Yongfeng Liu, Bo Cao, Bin Liu, Tiecheng Bai, Xiaoyong Li, Leyuan Mei, Xiangming Che.   

Abstract

BACKGROUND/AIMS: This study aimed to investigate the role of metastatic lymph node ratio (MLR) in the evaluation of prognosis of patients with gastric cancer at different T stages.
METHODOLOGY: Clinical information was reviewed retrospectively in a total 535 patients who underwent surgery for gastric cancer. The prognostic value of MLR was compared with that of pN determined according to the UICC/AJCC guidelines (7th Edition), and the characteristics and advantages of MLR were analyzed. Moreover, the role of MLR in the evaluation of prognosis of patients with gastric cancer at different pT stages was investigated.
RESULTS: Univariate Kaplan-Meier method was used for the analysis of survival, and the results showed that MLR was closely associated with the prognosis of these patients. Multivariate analysis with Cox proportional hazards regression model showed that MLR was a major independent risk factor in the prognosis of gastric cancer patients. The area under the ROC curve of MLR in predicting the death of gastric cancer patients within 5 years after surgery was not associated with pN stage. MLR was effective in predicting the prognosis of patients with stage pT2 or pT3 gastric cancer (P < 0.05).
CONCLUSIONS: MLR is an independent risk factor in the prognosis of gastric cancer. MLR has a prognostic ability comparable to that of pN stage in gastric cancer. Thus, it is more reliable than pN in the evaluation of prognosis of gastric cancer patients, especially those with stage pT2-pT3 gastric cancer.

Entities:  

Mesh:

Year:  2015        PMID: 25916091

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

1.  Validation of the 7th AJCC/UICC staging system for gastric cancer and a proposal for a new TNM system based on a prognostic score: a retrospective multicenter study.

Authors:  Oh Kyoung Kwon; Se Won Kim; Hyun-Dong Chae; Seung Wan Ryu; Ho Young Chung; Sang Woon Kim; Won Kee Lee; Wansik Yu
Journal:  Ann Surg Treat Res       Date:  2016-11-25       Impact factor: 1.859

2.  Preoperative SCC Antigen, CRP Serum Levels, and Lymph Node Density in Oral Squamous Cell Carcinoma.

Authors:  Mohamad Adel; Chung-Kan Tsao; Fu-Chan Wei; Huei-Tzu Chien; Chih-Hsiung Lai; Chun-Ta Liao; Hung-Ming Wang; Kang-Hsing Fan; Chung-Jan Kang; Joseph Tung-Chieh Chang; Shiang-Fu Huang
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

3.  Lymph nodes ratio based nomogram predicts survival of resectable gastric cancer regardless of the number of examined lymph nodes.

Authors:  Shangxiang Chen; Huamin Rao; Jianjun Liu; Qirong Geng; Jing Guo; Pengfei Kong; Shun Li; Xuechao Liu; Xiaowei Sun; Youqing Zhan; Dazhi Xu
Journal:  Oncotarget       Date:  2017-07-11

4.  Surgical Outcomes Associated with Operable Gastric Cancer in a Tertiary Care Indian Hospital.

Authors:  Joshua Franklyn; Sam V George; Myla Yacob; Vijay Abraham; Sudhakar Chandran; Tunny Sebastian; Inian Samarasam
Journal:  J Gastric Cancer       Date:  2017-03-20       Impact factor: 3.720

5.  Superiority of lymph node ratio-based staging system for prognostic prediction in 2575 patients with gastric cancer: validation analysis in a large single center.

Authors:  Lin-Yong Zhao; Chang-Chun Li; Lu-Yu Jia; Xiao-Long Chen; Wei-Han Zhang; Xin-Zu Chen; Kun Yang; Kai Liu; Yi-Gao Wang; Lian Xue; Bo Zhang; Zhi-Xin Chen; Jia-Ping Chen; Zong-Guang Zhou; Jian-Kun Hu
Journal:  Oncotarget       Date:  2016-08-09

6.  Preoperative Plasma Fibrinogen and Serum Albumin Score Is an Independent Prognostic Factor for Resectable Stage II-III Gastric Cancer.

Authors:  Menghui Wu; Yuchen Pan; Zhifang Jia; Yueqi Wang; Na Yang; Jianfeng Mu; Tianyu Zhou; Yaohua Guo; Jing Jiang; Xueyuan Cao
Journal:  Dis Markers       Date:  2019-10-29       Impact factor: 3.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.